• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体-2信号传导触发树突状细胞发育。

Protease-activated receptor-2 signaling triggers dendritic cell development.

作者信息

Fields Ryan C, Schoenecker Jonathan G, Hart Justin P, Hoffman Maureane R, Pizzo Salvatore V, Lawson Jeffrey H

机构信息

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Am J Pathol. 2003 Jun;162(6):1817-22. doi: 10.1016/S0002-9440(10)64316-7.

DOI:10.1016/S0002-9440(10)64316-7
PMID:12759239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1868121/
Abstract

Dendritic cells (DC) are potent antigen-presenting cells that govern the effector cell responses of the immune system. DC are thought to continuously develop from circulating progenitors in a process that is accelerated by inflammatory stimuli. However, the physiological signals that regulate the development of DC from precursor cells have not been well defined. Here we show that a serine protease acting via protease-activated receptor-2 (PAR-2) stimulates the development of DC from bone marrow progenitor cells cultured in granulocyte-macrophage colony-stimulating factor and IL-4. DC fail to develop in bone marrow cultures treated with soy bean trypsin inhibitor, a serine protease inhibitor, but this inhibition is overcome by a PAR-2 agonist peptide. DC do not spontaneously develop from the bone marrow of PAR-2-deficient mice, but can be stimulated to do so by inflammatory mediators. These results suggest that endogenous serine proteases stimulate DC development in vitro. Thus, serine proteases may help trigger adaptive immune responses in vivo.

摘要

树突状细胞(DC)是强大的抗原呈递细胞,可调控免疫系统的效应细胞反应。人们认为DC在炎症刺激加速的过程中持续从循环祖细胞发育而来。然而,调节DC从前体细胞发育的生理信号尚未明确界定。在此,我们表明,一种通过蛋白酶激活受体-2(PAR-2)起作用的丝氨酸蛋白酶可刺激在粒细胞-巨噬细胞集落刺激因子和白细胞介素-4中培养的骨髓祖细胞发育成DC。在用丝氨酸蛋白酶抑制剂大豆胰蛋白酶抑制剂处理的骨髓培养物中,DC无法发育,但PAR-2激动剂肽可克服这种抑制作用。DC不会从PAR-2缺陷小鼠的骨髓中自发发育,但可被炎症介质刺激发育。这些结果表明内源性丝氨酸蛋白酶在体外刺激DC发育。因此,丝氨酸蛋白酶可能有助于在体内触发适应性免疫反应。

相似文献

1
Protease-activated receptor-2 signaling triggers dendritic cell development.蛋白酶激活受体-2信号传导触发树突状细胞发育。
Am J Pathol. 2003 Jun;162(6):1817-22. doi: 10.1016/S0002-9440(10)64316-7.
2
Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique.使用改进培养技术分析大鼠骨髓来源树突状细胞的成熟状态
Histochem Cell Biol. 2002 Apr;117(4):351-62. doi: 10.1007/s00418-002-0384-4. Epub 2002 Feb 16.
3
Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow.转化生长因子-β1和肿瘤坏死因子-α对小鼠骨髓祖细胞来源的树突状细胞发育的对比作用。
Stem Cells. 1997;15(2):144-53. doi: 10.1002/stem.150144.
4
Impaired function of dendritic cells deficient in angiotensin II type 1 receptors.血管紧张素 II 型受体缺陷的树突状细胞功能受损。
J Pharmacol Exp Ther. 2010 Sep 1;334(3):854-62. doi: 10.1124/jpet.109.161760. Epub 2010 Jun 1.
5
Type I IFN regulate DC turnover in vivo.I型干扰素在体内调节树突状细胞的更新。
Eur J Immunol. 2009 Jul;39(7):1807-18. doi: 10.1002/eji.200939233.
6
Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.骨髓来源的未成熟树突状细胞在体内使同种异体反应性T细胞致敏,以实现对主要组织相容性复合体II类抗原不相合心脏移植的白细胞介素-4依赖性排斥反应。
Transplantation. 2003 Feb 15;75(3):407-13. doi: 10.1097/01.TP.0000044172.19087.22.
7
Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.白细胞介素-4对无血清条件下生成的骨髓源性小鼠树突状细胞的表型和功能的影响。
Scand J Immunol. 2005 Mar;61(3):251-9. doi: 10.1111/j.1365-3083.2005.01556.x.
8
Accelerated differentiation of bone marrow-derived dendritic cells in atopic prone mice.特应性易感小鼠骨髓来源树突状细胞的加速分化
Int Immunopharmacol. 2008 Dec 20;8(13-14):1737-43. doi: 10.1016/j.intimp.2008.08.006. Epub 2008 Sep 5.
9
The signalling imprints of nanoparticle uptake by bone marrow derived dendritic cells.骨髓来源树突状细胞摄取纳米颗粒的信号印记。
Methods. 2013 May 1;60(3):275-83. doi: 10.1016/j.ymeth.2013.02.009. Epub 2013 Feb 28.
10
Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.肿瘤坏死因子与粒细胞-巨噬细胞集落刺激因子及其他细胞因子在体外调控人骨髓中早期双能CD34+祖细胞来源的树突状细胞生长过程中的相互作用。
J Immunol. 1992 Oct 15;149(8):2681-8.

引用本文的文献

1
Inhibition of thrombin on endothelium enhances recruitment of regulatory T cells during IRI and when combined with adoptive Treg transfer, significantly protects against acute tissue injury and prolongs allograft survival.抑制凝血酶可增强 IRI 期间调节性 T 细胞的募集,当与过继性 Treg 转移联合使用时,可显著防止急性组织损伤并延长移植物存活时间。
Front Immunol. 2023 Jan 30;13:980462. doi: 10.3389/fimmu.2022.980462. eCollection 2022.
2
Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity.蛋白酶激活受体-2:在哮喘发病机制中的作用及作为疾病严重程度生物标志物的效用。
Front Med (Lausanne). 2022 Jul 29;9:954990. doi: 10.3389/fmed.2022.954990. eCollection 2022.
3
Protease-activated receptors in health and disease.蛋白酶激活受体在健康和疾病中的作用。
Physiol Rev. 2023 Jan 1;103(1):717-785. doi: 10.1152/physrev.00044.2021. Epub 2022 Jul 28.
4
Protease Activated Receptor 4 as a Novel Modulator of Regulatory T Cell Function.蛋白酶激活受体 4作为调节性 T 细胞功能的新型调节剂。
Front Immunol. 2019 Jun 18;10:1311. doi: 10.3389/fimmu.2019.01311. eCollection 2019.
5
Cathepsin S Is Involved in Th17 Differentiation Through the Upregulation of IL-6 by Activating PAR-2 after Systemic Exposure to Lipopolysaccharide from .组织蛋白酶S通过在全身暴露于脂多糖后激活蛋白酶激活受体-2上调白细胞介素-6参与辅助性T细胞17分化。
Front Pharmacol. 2017 Jul 17;8:470. doi: 10.3389/fphar.2017.00470. eCollection 2017.
6
TLR4-mediated immunomodulatory properties of the bacterial metalloprotease arazyme in preclinical tumor models.在临床前肿瘤模型中,细菌金属蛋白酶arazyme的TLR4介导的免疫调节特性。
Oncoimmunology. 2016 May 5;5(7):e1178420. doi: 10.1080/2162402X.2016.1178420. eCollection 2016 Jul.
7
EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.血液凝固起始复合物通过依赖内皮蛋白C受体(EPCR)的蛋白酶激活受体2(PAR2)激活来调节小鼠中脂多糖(LPS)触发的干扰素反应。
Blood. 2015 Apr 30;125(18):2845-54. doi: 10.1182/blood-2014-11-610717. Epub 2015 Mar 2.
8
Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer.肥大细胞可塑性与免疫、炎症及癌症中的1-磷酸鞘氨醇
Mol Immunol. 2015 Jan;63(1):104-12. doi: 10.1016/j.molimm.2014.03.018. Epub 2014 Apr 22.
9
Trypsin potentiates human fibrocyte differentiation.胰蛋白酶促进人成纤维细胞分化。
PLoS One. 2013 Aug 7;8(8):e70795. doi: 10.1371/journal.pone.0070795. eCollection 2013.
10
Protease-activated receptor-2 signalling by tissue factor on dendritic cells suppresses antigen-specific CD4+ T-cell priming.组织因子通过蛋白酶激活受体-2 信号转导抑制树突状细胞中的抗原特异性 CD4+T 细胞的启动。
Immunology. 2013 Jun;139(2):219-26. doi: 10.1111/imm.12073.

本文引用的文献

1
Exposure of mice to topical bovine thrombin induces systemic autoimmunity.将小鼠局部暴露于牛凝血酶会诱发全身性自身免疫。
Am J Pathol. 2001 Nov;159(5):1957-69. doi: 10.1016/S0002-9440(10)63043-X.
2
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.蛋白酶信号传导与组织因子启动凝血的机制性耦合。
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7742-7. doi: 10.1073/pnas.141126698.
3
Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.树突状细胞与免疫调控:提高抗原呈递效率
Mt Sinai J Med. 2001 May;68(3):160-6.
4
Proteinase-activated receptors.蛋白酶激活受体
Pharmacol Rev. 2001 Jun;53(2):245-82.
5
Amelioration of collagen-induced arthritis by thrombin inhibition.通过抑制凝血酶改善胶原诱导的关节炎。
J Clin Invest. 2001 Mar;107(5):631-40. doi: 10.1172/JCI11064.
6
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages.白细胞介素-6将单核细胞的分化从树突状细胞转变为巨噬细胞。
Nat Immunol. 2000 Dec;1(6):510-4. doi: 10.1038/82763.
7
Thrombin signalling and protease-activated receptors.凝血酶信号传导与蛋白酶激活受体
Nature. 2000 Sep 14;407(6801):258-64. doi: 10.1038/35025229.
8
Immunobiology of dendritic cells.树突状细胞的免疫生物学
Annu Rev Immunol. 2000;18:767-811. doi: 10.1146/annurev.immunol.18.1.767.
9
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.组织因子及因子X依赖的凝血因子VIIa对蛋白酶激活受体2的激活作用。
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5255-60. doi: 10.1073/pnas.97.10.5255.
10
Apoptosis or necrosis for tumor immunotherapy: what's in a name?用于肿瘤免疫治疗的凋亡或坏死:名称有何含义?
J Mol Med (Berl). 1999 Dec;77(12):824-33. doi: 10.1007/s001099900066.